ResearcherUniversity of North Carolina at Chapel HillNo recent work listed
Daniel E. Michaud
Matched on ORCID iD 0000-0001-7816-3924; OpenAlex author ID A5044412259; NIH RePORTER profile ID 15059602. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 3, last author 0)
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 9
2018: 1 paper · 2019: none · 2020: 3 papers · 2021: 1 paper, 1 grant
Papers 5
- B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer. Co-author DOI 10.3389/fimmu.2021.745873↗
- Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3. Co-author DOI 10.1016/j.cyto.2019.154817↗
- Rab27a plays a dual role in metastatic propensity of pancreatic cancer. First author DOI 10.1038/s41598-020-64248-1↗
- B cell-Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer. First author DOI 10.1158/2326-6066.cir-19-0349↗
- IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer. First author DOI 10.1158/2326-6066.cir-17-0710↗
Grants 1
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuliya Pylayeva-Gupta · 5 shared papers, 2018–2021 · strength 0.65
- Paper B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer. DOI 10.3389/fimmu.2021.745873↗
- Paper Rab27a plays a dual role in metastatic propensity of pancreatic cancer. DOI 10.1038/s41598-020-64248-1↗
- Paper Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3. DOI 10.1016/j.cyto.2019.154817↗
- Bhalchandra Mirlekar · 4 shared papers, 2018–2021 · strength 0.50
- Paper B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer. DOI 10.3389/fimmu.2021.745873↗
- Paper Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3. DOI 10.1016/j.cyto.2019.154817↗
- Paper IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer. DOI 10.1158/2326-6066.cir-17-0710↗
- Nancy Porterfield Kren · 2 shared papers, 2020 · strength 0.24
- William G. Hawkins · 1 shared paper, 2020 · strength 0.09
- Naim U. Rashid · 1 shared paper, 2020 · strength 0.09
- Jen Jen Yeh · 1 shared paper, 2020 · strength 0.09
- Ryan C Fields · 1 shared paper, 2020 · strength 0.09
- David G DeNardo · 1 shared paper, 2020 · strength 0.09
- Autumn J. McRee · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.